Display options
Share it on

Rare Dis. 2013 May 02;1:e24883. doi: 10.4161/rdis.24883. eCollection 2013.

IGSF1 deficiency syndrome: A newly uncovered endocrinopathy.

Rare diseases (Austin, Tex.)

Sjoerd D Joustra, A S Paul van Trotsenburg, Yu Sun, Monique Losekoot, Daniel J Bernard, Nienke R Biermasz, Wilma Oostdijk, Jan M Wit

Affiliations

  1. Department of Pediatrics; Leiden University Medical Center; Leiden, The Netherlands ; Department of Endocrinology and Metabolic Disorders; Leiden University Medical Center; Leiden, The Netherlands.
  2. Department of Pediatric Endocrinology; Emma Children's Hospital; Academic Medical Center; University of Amsterdam; Amsterdam, The Netherlands.
  3. Center for Human and Clinical Genetics; Leiden University Medical Center; Leiden, The Netherlands.
  4. Department of Pharmacology and Therapeutics; McGill University; Montreal, QC Canada.
  5. Department of Endocrinology and Metabolic Disorders; Leiden University Medical Center; Leiden, The Netherlands.
  6. Department of Pediatrics; Leiden University Medical Center; Leiden, The Netherlands.

PMID: 25002994 PMCID: PMC3915563 DOI: 10.4161/rdis.24883

Abstract

A recently uncovered X-linked syndrome, caused by loss-of-function of IGSF1, is characterized by congenital central hypothyroidism and macroorchidism, variable prolactin deficiency, occasional growth hormone deficiency, delayed pubertal testosterone secretion and obesity. We propose to call this endocrinopathy "IGSF1 deficiency syndrome." Based on an estimated incidence of isolated congenital central hypothyroidism of 1:65,000, we predict that the incidence of IGSF1 deficiency related hypothyroidism is approximately 1:100,000. IGSF1 encodes a plasma membrane immunoglobulin superfamily glycoprotein that is highly expressed in pituitary and testis, but is of unknown function. The variable profile of pituitary dysfunction suggests that IGSF1 may play a role in pituitary paracrine regulation. The clinical significance of the syndrome, particularly the clinical consequences of untreated hypothyroidism, justifies screening family members of patients with IGSF1 mutations for carriership and to study potential carriers of IGSF1 mutations, including patients with idiopathic central hypothyroidism, combined GH and TSH deficiency, macroorchidism or delayed puberty.

Keywords: IGSF1; central hypothyroidism; macroorchidism; obesity; prolactin

References

  1. Mol Cell Biol. 2003 Jul;23(14):4882-91 - PubMed
  2. Neuroscientist. 2012 Oct;18(5):452-66 - PubMed
  3. N Engl J Med. 2009 Feb 12;360(7):731-4 - PubMed
  4. Semin Immunol. 2003 Aug;15(4):215-23 - PubMed
  5. Curr Opin Cell Biol. 2007 Oct;19(5):543-50 - PubMed
  6. J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S225-33 - PubMed
  7. J Pediatr Endocrinol Metab. 2003 Mar;16 Suppl 2:253-7 - PubMed
  8. J Clin Endocrinol Metab. 2001 Apr;86(4):1600-4 - PubMed
  9. J Pediatr Endocrinol Metab. 1996 Nov-Dec;9(6):617-22 - PubMed
  10. Cell Tissue Res. 2008 Nov;334(2):283-94 - PubMed
  11. Endocrinology. 1998 Jan;139(1):156-62 - PubMed
  12. Mol Endocrinol. 2001 Apr;15(4):654-67 - PubMed
  13. Reproduction. 2003 Jun;125(6):769-84 - PubMed
  14. Biotechnol J. 2008 Dec;3(12):1564-80 - PubMed
  15. Pediatrics. 2005 Jul;116(1):168-73 - PubMed
  16. Mol Cell Endocrinol. 2002 Oct 31;196(1-2):79-93 - PubMed
  17. Clin Dysmorphol. 2005 Jul;14(3):133-135 - PubMed
  18. Am J Med Genet A. 2003 Apr 1;118A(1):49-51 - PubMed
  19. Genomics. 1998 Mar 1;48(2):157-62 - PubMed
  20. J Clin Endocrinol Metab. 2005 Jun;90(6):3350-9 - PubMed
  21. Endocr J. 2013;60(2):245-9 - PubMed
  22. Cell Tissue Res. 2005 Oct;322(1):133-40 - PubMed
  23. Gene. 1998 Jul 3;214(1-2):1-6 - PubMed
  24. Nat Genet. 2012 Dec;44(12):1375-81 - PubMed
  25. J Neuroendocrinol. 2008 Jan;20(1):1-70 - PubMed
  26. J Biol Chem. 2008 Dec 26;283(52):36369-76 - PubMed
  27. Horm Res Paediatr. 2011;76(1):56-64 - PubMed
  28. Nature. 1986 Apr 10-16;320(6062):488-9 - PubMed
  29. Cell Mol Immunol. 2010 Jan;7(1):11-9 - PubMed
  30. J Exp Med. 2011 Nov 21;208(12):2545-60 - PubMed

Publication Types